Short Term Analgesic Effects of 5% Dextrose Epidural Injections for Chronic Low Back Pain: A Randomized Controlled Trial
Liza Maniquis-Smigel, Kenneth Dean Reeves, Howard Jeffrey Rosen, John Lyftogt, Cassie Graham-Coleman, An-Lin Cheng, David Rabago, Liza Maniquis-Smigel, Kenneth Dean Reeves, Howard Jeffrey Rosen, John Lyftogt, Cassie Graham-Coleman, An-Lin Cheng, David Rabago
Abstract
Background: Hypertonic dextrose injection (prolotherapy) is reported to reduce pain including non-surgical chronic low back pain (CLBP), and subcutaneous injection of 5% dextrose is reported to reduce neurogenic pain, hyperalgesia and allodynia. The mechanism in both cases is unclear, though a direct effect of dextrose on neurogenic pain has been proposed. This study assessed the short-term analgesic effects of epidural 5% dextrose injection compared with saline for non-surgical CLBP.
Methods: Randomized double-blind (injector, participant) controlled trial. Adults with moderate-to-severe non-surgical low back pain with radiation to gluteal or leg areas for at least 6 months received a single epidurogram-confirmed epidural injection of 10 mL of 5% dextrose or 0.9% saline using a published vertical caudal injection technique. The primary outcome was change in a numerical rating scale (NRS, 0 - 10 points) pain score between baseline and 15 minutes; and 2, 4, and 48 hours and 2 weeks post-injection. The secondary outcome was percentage of participants achieving 50% or more pain improvement at 4 hours.
Results and conclusions: No baseline differences existed between groups; 35 participants (54 ± 10.7 years old; 11 female) with moderate-to-severe CLBP (6.7 ± 1.3 points) for 10.6 ± 10.5 years. Dextrose participants reported greater NRS pain score change at 15 minutes (4.4 ± 1.7 vs 2.4 ± 2.8 points; P = 0.015), 2 hours (4.6 ± 1.9 vs 1.8 ± 2.8 points; P = 0.001), 4 hours (4.6 ± 2.0 vs 1.4 ± 2.3 points; P < 0.001), and 48 hours (3.0 ± 2.3 vs 1.0 ± 2.1 points; P = 0.012), but not at 2 weeks (2.1 ± 2.9 vs 1.2 ± 2.4 points; P = 0.217). Eighty four percent (16/19) of dextrose recipients and 19% (3/16) of saline recipients reported ≥ 50% pain reduction at 4 hours (P < 0.001). These findings suggest a neurogenic effect of 5% dextrose on pain at the dorsal root level; waning pain control at 2 weeks suggests the need to assess the effect of serial dextrose epidural injections in a long-term study with robust outcome assessment.
Keywords: Analgesia; Anesthesia; Caudal; Dextrose; Epidural.
Figures
References
- Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull World Health Organ. 2003;81(9):646–56.
- Dagenais S, Caro J, Haldeman S. A systematic review of low back pain cost of illness studies in the United States and internationally. Spine J. 2008;8(1):8–20. doi: 10.1016/j.spinee.2007.10.005.
- Wilkerson RG, Kim HK, Windsor TA, Mareiniss DP. The Opioid Epidemic in the United States. Emerg Med Clin North Am. 2016;34(2):e1–e23. doi: 10.1016/j.emc.2015.11.002.
- Rahimzadeh P, Sharma V, Imani F, Faiz HR, Ghodraty MR, Nikzad-Jamnani AR, et al. Adjuvant hyaluronidase to epidural steroid improves the quality of analgesia in failed back surgery syndrome: a prospective randomized clinical trial. Pain Physician. 2014;17(1):E75–82.
- Patel VB, Wasserman R, Imani F. Interventional Therapies for Chronic Low Back Pain: A Focused Review (Efficacy and Outcomes). Anesth Pain Med. 2015;5(4):ee29716. doi: 10.5812/aapm.29716.
- Veizi E, Hayek S. Interventional therapies for chronic low back pain. Neuromodulation. 2014;17 Suppl 2:31–45. doi: 10.1111/ner.12250.
- Hoy D, March L, Brooks P, Blyth F, Woolf A, Bain C, et al. The global burden of low back pain: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(6):968–74. doi: 10.1136/annrheumdis-2013-204428.
- Rabago D, Slattengren A, Zgierska A. Prolotherapy in primary care practice. Prim Care. 2010;37(1):65–80. doi: 10.1016/j.pop.2009.09.013.
- Rabago D, Patterson JJ, Mundt M, Kijowski R, Grettie J, Segal NA, et al. Dextrose prolotherapy for knee osteoarthritis: a randomized controlled trial. Ann Fam Med. 2013;11(3):229–37. doi: 10.1370/afm.1504.
- DeChellis DM, Cortazzo MH. Regenerative medicine in the field of pain medicine: Prolotherapy, platelet-rich plasma therapy, and stem cell therapy—Theory and evidence. Technique Region Anesth Pain Manag. 2011;15(2):74–80. doi: 10.1053/j.trap.2011.05.002.
- Mankowitz E, Brock-Utne JG, Cosnett JE, Green-Thompson R. Epidural ketamine. A preliminary report. S Afr Med J. 1982;61(12):441–2.
- White JL, Stevens RA, Kao TC. Differential sensory block: spinal vs epidural with lidocaine. Can J Anaesth. 1998;45(11):1049–53. doi: 10.1007/BF03012390.
- Munishankar B, Fettes P, Moore C, McLeod GA. A double-blind randomised controlled trial of paracetamol, diclofenac or the combination for pain relief after caesarean section. Int J Obstet Anesth. 2008;17(1):9–14. doi: 10.1016/j.ijoa.2007.06.006.
- Park YR, Eastwood DW. Dextrose affects gravitational spread of epidural anesthesia. Anesthesiology. 1980;52(5):439–41.
- Rabago D, Kijowski R, Woods M, Patterson JJ, Mundt M, Zgierska A, et al. Association between disease-specific quality of life and magnetic resonance imaging outcomes in a clinical trial of prolotherapy for knee osteoarthritis. Arch Phys Med Rehabil. 2013;94(11):2075–82. doi: 10.1016/j.apmr.2013.06.025.
- Lyftogt J. Subcutaneous prolotherapy for Achilles tendinopathy: The best solution? Aust Musculoskelet Med. 2007;12(2):107.
- Lyftogt J. Subcutaneous prolotherapy treatment of refractory knee, shoulder, and lateral elbow pain. Aust Musculoskelet Med. 2007;12(2):110.
- Lyftogt J. Prolotherapy for recalcitrant lumbago. Aust Musculoskelet Med. 2008;13(1):18.
- Yelland MJ, Sweeting KR, Lyftogt JA, Ng SK, Scuffham PA, Evans KA. Prolotherapy injections and eccentric loading exercises for painful Achilles tendinosis: a randomised trial. Br J Sports Med. 2011;45:421–8.
- Maniquis Smigel L, Dean Reeves K, Jeffrey Rosen H, Patrick Rabago D. Vertical Small-Needle Caudal Epidural Injection Technique. Anesth Pain Med. 2016;6(3):ee35340. doi: 10.5812/aapm.35340.
- Ferraz MB, Quaresma MR, Aquino LR, Atra E, Tugwell P, Goldsmith CH. Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. J Rheumatol. 1990;17(8):1022–4.
- Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8(4):283–91. doi: 10.1016/j.ejpain.2003.09.004.
- Manchikanti L, Knezevic NN, Boswell MV, Kaye AD, Hirsch JA. Epidural Injections for Lumbar Radiculopathy and Spinal Stenosis: A Comparative Systematic Review and Meta-Analysis. Pain Physician. 2016;19(3):E365–410.
- Ostelo RW, Deyo RA, Stratford P, Waddell G, Croft P, Von Korff M, et al. Interpreting change scores for pain and functional status in low back pain: towards international consensus regarding minimal important change. Spine (Phila Pa 1976). 2008;33(1):90–4. doi: 10.1097/BRS.0b013e31815e3a10.
- Lee A, Ray D, Littlewood DG, Wildsmith JA. Effect of dextrose concentration on the intrathecal spread of amethocaine. Br J Anaesth. 1988;61(2):135–8.
- Hood DD, Mallak KA, Eisenach JC, Tong C. Interaction between intrathecal neostigmine and epidural clonidine in human volunteers. Anesthesiology. 1996;85(2):315–25.
- Hasenbos MA, Gielen MJ. Anaesthesia for bullectomy. A technique with spontaneous ventilation and extradural blockade. Anaesthesia. 1985;40(10):977–80.
- Connelly NR, Dunn SM, Ingold V, Villa EA. The use of fentanyl added to morphine-lidocaine-epinephrine spinal solution in patients undergoing cesarean section. Anesth Analg. 1994;78(5):918–20.
- Liu S, Pollock JE, Mulroy MF, Allen HW, Neal JM, Carpenter RL. Comparison of 5% with dextrose, 1.5% with dextrose, and 1.5% dextrose-free lidocaine solutions for spinal anesthesia in human volunteers. Anesth Analg. 1995;81(4):697–702.
- McLeod GA. Density of spinal anaesthetic solutions of bupivacaine, levobupivacaine, and ropivacaine with and without dextrose. Br J Anaesth. 2004;92(4):547–51. doi: 10.1093/bja/aeh094.
- Chauvin M, Samii K, Schermann JM, Sandouk P, Bourdon R, Viars P. Plasma concentration of morphine after i.m., extradural and intrathecal administration. Br J Anaesth. 1981;53(9):911–3.
- Torda TA, Pybus DA. Comparison of four narcotic analgesics for extradural analgesia. Br J Anaesth. 1982;54(3):291–5.
- Badner NH, Sandler AN, Koren G, Lawson SL, Klein J, Einarson TR. Lumbar epidural fentanyl infusions for post-thoracotomy patients: analgesic, respiratory, and pharmacokinetic effects. J Cardiothorac Anesth. 1990;4(5):543–51.
- Burm AG. Clinical pharmacokinetics of epidural and spinal anaesthesia. Clin Pharmacokinet. 1989;16(5):283–311. doi: 10.2165/00003088-198916050-00002.
- Bertrand H, Reeves KD, Bennett CJ, Bicknell S, Cheng AL. Dextrose Prolotherapy Versus Control Injections in Painful Rotator Cuff Tendinopathy. Arch Phys Med Rehabil. 2016;97(1):17–25. doi: 10.1016/j.apmr.2015.08.412.
- Dumais R, Benoit C, Dumais A, Babin L, Bordage R, de Arcos C, et al. Effect of regenerative injection therapy on function and pain in patients with knee osteoarthritis: a randomized crossover study. Pain Med. 2012;13(8):990–9. doi: 10.1111/j.1526-4637.2012.01422.x.
- Reeves KD, Hassanein K. Randomized prospective double-blind placebo-controlled study of dextrose prolotherapy for knee osteoarthritis with or without ACL laxity. Alternat Ther Health Med. 2000;6(2):68–80.
- Sit RW, Chung V, Reeves KD, Rabago D, Chan KK, Chan DC, et al. Hypertonic dextrose injections (prolotherapy) in the treatment of symptomatic knee osteoarthritis: A systematic review and meta-analysis. Sci Rep. 2016;6:25247. doi: 10.1038/srep25247.
- Topol GA, Podesta LA, Reeves KD, Raya MF, Fullerton BD, Yeh HW. Hyperosmolar dextrose injection for recalcitrant Osgood-Schlatter disease. Pediatrics. 2011;128(5):e1121–8. doi: 10.1542/peds.2010-1931.
- Jahangiri A, Moghaddam FR, Najafi S. Hypertonic dextrose versus corticosteroid local injection for the treatment of osteoarthritis in the first carpometacarpal joint: a double-blind randomized clinical trial. J Orthop Sci. 2014;19(5):737–43. doi: 10.1007/s00776-014-0587-2.
- Reeves KD, Hassanein K. Randomized, prospective, placebo-controlled double-blind study of dextrose prolotherapy for osteoarthritic thumb and finger (DIP, PIP, and trapeziometacarpal) joints: evidence of clinical efficacy. J Altern Complement Med. 2000;6(4):311–20. doi: 10.1089/10755530050120673.
- Scarpone M, Rabago DP, Zgierska A, Arbogast G, Snell E. The efficacy of prolotherapy for lateral epicondylosis: a pilot study. Clin J Sport Med. 2008;18(3):248–54. doi: 10.1097/JSM.0b013e318170fc87.
- Rabago D, Lee KS, Ryan M, Chourasia AO, Sesto ME, Zgierska A, et al. Hypertonic dextrose and morrhuate sodium injections (prolotherapy) for lateral epicondylosis (tennis elbow): results of a single-blind, pilot-level, randomized controlled trial. Am J Phys Med Rehabil. 2013;92(7):587–96. doi: 10.1097/PHM.0b013e31827d695f.
- Kim WM, Lee HG, Jeong CW, Kim CM, Yoon MH. A randomized controlled trial of intra-articular prolotherapy versus steroid injection for sacroiliac joint pain. J Altern Complement Med. 2010;16(12):1285–90. doi: 10.1089/acm.2010.0031.
- Topol GA, Podesta LA, Reeves KD, Giraldo MM, Johnson LL, Grasso R, et al. Chondrogenic effect of intra-articular hypertonic-dextrose (prolotherapy) in severe knee osteoarthritis. PMR. 2016;8(11):1072–1082.
- Donaldson L. Neurogenic mechanisms in arthritis. In: Jancso G, editor. Neurogenic Inflammation in Health and Disease. Amsterdam: Elsevier; 2009. pp. 211–41.
- Malek N, Pajak A, Kolosowska N, Kucharczyk M, Starowicz K. The importance of TRPV1-sensitisation factors for the development of neuropathic pain. Mol Cell Neurosci. 2015;65:1–10. doi: 10.1016/j.mcn.2015.02.001.
- Mohammadi-Farani A, Ghazi-Khansari M, Sahebgharani M. Glucose concentration in culture medium affects mRNA expression of TRPV1 and CB1 receptors and changes capsaicin toxicity in PC12 cells. Iran J Basic Med Sci. 2014;17(9):673–378.
- Bertrand H, Kyriazis M, Reeves KD, Lyftogt J, Rabago D. Topical Mannitol Reduces Capsaicin-Induced Pain: Results of a Pilot-Level, Double-Blind, Randomized Controlled Trial. PM R. 2015;7(11):1111–7. doi: 10.1016/j.pmrj.2015.05.002.
- Kim MY, Na YM, Moon JH. Comparison on treatment effects of dextrose water, saline, and lidocaine for trigger point injection. J Korean Acad Rehabil Med. 1997;21(5):967–73.
Source: PubMed